Fampyra

Acorda Therapeutics (NASDAQ: ACOR) has been off to a hot start in 2013. The stock is already up around 16 percent on the year and shares are trading near 52-week high levels at roughly $29. The company has a market cap of $1.16 billion at current levels and the stock has risen over nine percent...